A Phase 3 interventional study of pain management and ketoprofen in Acute Postoperative Pain, Non-steroidal Anti-inflammatory Drugs and Cardiac Surgery, sponsored by Centre Hospitalier Universitaire, Amiens. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-07-23.
Sponsored by Centre Hospitalier Universitaire, Amiens · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 103 studies in Pain, Postoperative with a site in France — 18 open to participants now, 21 under way, 3 of them phase 3. Pain, Postoperative · France.
Among the 103 studies in Pain, Postoperative with a site in France, this one is the 22nd largest by planned enrollment of the 83 interventional ones that give a count, is one of 6 that started in 2024, is one of 19 in phase 3, reaches primary completion later than 6 of the 20 other live ones, and was the 84th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →18 of the 103 studies in Pain, Postoperative with a site in France are open now. Recruiting first, the newest first:
Saint-Gregoire Private Hospital Center · Sites in France
Ages 18+
Centre Hospitalier Universitaire, Amiens · Sites in France
Ages 18+ · Women only
GCS Ramsay Santé pour l'Enseignement et la Recherche · Sites in France
Ages 18+
Centre Hospitalier Universitaire, Amiens · Sites in France
Ages 18+
Centre Hospitalier Universitaire, Amiens · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
103 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 13 · Phase 3 22 · Phase 4 10
First in 2003; this study’s year is marked. 6 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 238 is above the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 140 across the 83 interventional studies, 128 across the 20 observational. Of the 72 that completed or were terminated, 5 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 103 have an industry lead sponsor. The 10 most frequent:
Centre Hospitalier Universitaire, Amiens is the lead sponsor of 586 studies on the registry; 185 are open to participants now.
Centre Hospitalier Universitaire, Amiens has 8 studies filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
11 of the studies in Pain, Postoperative with a site in France that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06381063Phase 3Centre Hospitalier Universitaire, AmiensNon-steroidal Anti-inflammatory in Cardiac Surgery | 2027-03 |
| NCT04576078Hospices Civils de LyonPost-operative Analgesic Effect of Oral Nefopam | 2026-12-30 |
| NCT06555107Centre Hospitalier Universitaire, AmiensAcute Preoperative Pain and Chronic Post-surgical Pain in Emergency Surgery | 2027-01 |
| NCT04219956Nantes University HospitalStudy to Evaluate the Efficacy of a Polyamine-deficient Diet for Treating Postoperative Pain After Abdominal Surgery | 2027-04 |
| NCT07603271Institute Arnault Tzanck, FranceEarly Screening of Chronic Post-sternotomy Pain Using the DN4-i Questionnaire | 2027-05-03 |
Add all 11 to your calendar (.ics) → With an account.
Among the 103 studies in Pain, Postoperative with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Non-steroidal anti-inflammatory drugs (NSAID) are part the multimodal strategy in pain management after surgery. However, major concerns are raised in cardiac surgery given the potential side effects of NSAID with more bleeding and acute kidney injury. The investigators hypothesized that NSAID are safe in the early postoperative course after cardiac surgery with respect to contraindication.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Ketoprofen 100 mg twice a day, during 48 after surgery, intravenous administration
Drug: pain management · Drug: ketoprofen
Placebo twice a day, during 48 h after surgery, intravenous administration
Drug: pain management · Drug: PLacebo
o Pain management in both arms Intraoperative time: intravenous ketamine 0.5 mg kg-1, intravenous dexamethasone 8 mg Postoperative time: paracetamol 1 g every 6 hours a day, nefopam 20 every 8 hours a day, patient control analgesia with morphine or oxycontin
Ketoprofen 100 mg twice a day, during 48 after surgery, intravenous administration
Placebo twice a day, during 48 h after surgery, intravenous administration
reduction in pain intensity during chest physiotherapy at 24 hours from the end of surgery
Pain intensity will be assessed using the NRS at 24 hours from the end of surgery during chest physiotherapy
Time frame: at 24 hours
NSAIDs reduce postoperative at rest at 24 hours from the end of surgery
Pain intensity will be assessed at rest at 24 hours from the end surgery using the numerous rating scale (NRS) graded from 1 (no pain) to 10 (high pain intensity)
Time frame: at 24 hours
Change in pain trajectory during the first 7 days after cardiac surgery
Pain trajectory will be assessed every day using NRS and trajectory will be defined as following
Time frame: 7 days
Change in cumulative opioid within 48 hours after surgery
Total dose of oxynorm or morphine will be recorded from the end of surgery to 48 h after and expressed in milligram
Time frame: 48 hours
Change in pulmonary postoperative complications within 7 days after surgery
Postoperative pulmonary complications will be defined by the occurrence of at least one item among following: atelectasis, pneumonia, acute respiratory distress syndrome, acute respiratory failure, bronchospasm
Time frame: 7 days
Plan to share: No
Started Mar 2024 (actual). Primary completion is estimated for Mar 2027, 36 months after the start.
Of 124 non-industry phase 3 interventional studies under Pain, Postoperative, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 36 months is above that.
Counting every sponsor, half of 167 studies reached it within 17 months; a quarter within 8 and three quarters within 30.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire, Amiens →